Arihant Capital Markets Board Meeting Date
Arihant Capital Markets will hold a board meeting on 18 November 2026 to consider sponsoring a Mutual Fund. Trading window is closed until the news is public.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Arihant Capital Markets will hold a board meeting on 18 November 2026 to consider sponsoring a Mutual Fund. Trading window is closed until the news is public.
Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.
Arihant Capital Markets Ltd reported revenue from operations of ₹75.8 Cr (+33.0% YoY) and net profit of ₹20.9 Cr (+59.5% YoY) for Q2 FY27.
Arihant Capital Markets will hold a board meeting on 30-Oct-2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30-Sep-2026. The trading window is closed from 01-Oct-2026.
Arihant Capital Markets Ltd submitted its quarterly shareholding pattern report for the period ended September 30, 2026, as required under SEBI regulations.
Arihant Capital Markets Ltd held its 34th Annual General Meeting, approving financial statements for FY2026 and declaring a dividend of Rs. 0.50 per share.
Arihant Capital Markets Limited issued notice for its Annual General Meeting scheduled for 26-Sep-2026. Shareholders will consider financial statements, dividends, and director re-appointment.
Arihant Capital Markets Limited has submitted its Integrated Annual Report for the fiscal year 2025-26 along with the notice for its 34th Annual General Meeting.
Arihant Capital Markets fixed September 19, 2026, as the record date for a proposed 50% final dividend. The 34th AGM is scheduled for September 26, 2026.
Arihant Capital Markets Limited has appointed Mr. Sanjeev Jain as its new Chief Financial Officer, effective August 20, 2026. This appointment follows board and committee approval.